• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

瘤内递送灭活的安卡拉改良痘苗病毒(iMVA)通过STING和Batf3依赖性树突状细胞诱导全身抗肿瘤免疫。

Intratumoral delivery of inactivated modified vaccinia virus Ankara (iMVA) induces systemic antitumor immunity via STING and Batf3-dependent dendritic cells.

作者信息

Dai Peihong, Wang Weiyi, Yang Ning, Serna-Tamayo Cristian, Ricca Jacob M, Zamarin Dmitriy, Shuman Stewart, Merghoub Taha, Wolchok Jedd D, Deng Liang

机构信息

Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.

Molecular Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.

出版信息

Sci Immunol. 2017 May 19;2(11). doi: 10.1126/sciimmunol.aal1713.

DOI:10.1126/sciimmunol.aal1713
PMID:28763795
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5559204/
Abstract

Advanced cancers remain a therapeutic challenge despite recent progress in targeted therapy and immunotherapy. Novel approaches are needed to alter the tumor immunosuppressive microenvironment and to facilitate the recognition of tumor antigens that leads to antitumor immunity. Poxviruses, such as modified vaccinia virus Ankara (MVA), have potential as immunotherapeutic agents. We show that infection of conventional dendritic cells (DCs) with heat- or ultraviolet-inactivated MVA leads to higher levels of interferon induction than MVA alone through the cGAS (cyclic guanosine monophosphate-adenosine monophosphate synthase)-STING cytosolic DNA-sensing pathway. Intratumoral injection of inactivated MVA (iMVA) was effective and generated adaptive antitumor immunity in murine melanoma and colon cancer models. iMVA-induced antitumor therapy was less effective in STING- or Batf3-deficient mice than in wild-type mice, indicating that both cytosolic DNA sensing and Batf3-dependent CD103/CD8α DCs are essential for iMVA immunotherapy. The combination of intratumoral delivery of iMVA and systemic delivery of immune checkpoint blockade generated synergistic antitumor effects in bilateral tumor implantation models as well as in a unilateral large established tumor model. Our results suggest that inactivated vaccinia virus could be used as an immunotherapeutic agent for human cancers.

摘要

尽管在靶向治疗和免疫治疗方面取得了最新进展,但晚期癌症仍然是一个治疗挑战。需要新的方法来改变肿瘤免疫抑制微环境,并促进对导致抗肿瘤免疫的肿瘤抗原的识别。痘病毒,如改良安卡拉痘苗病毒(MVA),具有作为免疫治疗剂的潜力。我们发现,用热灭活或紫外线灭活的MVA感染传统树突状细胞(DC),通过cGAS(环磷酸鸟苷-磷酸腺苷合酶)-STING胞质DNA感应途径,比单独使用MVA能诱导更高水平的干扰素。在小鼠黑色素瘤和结肠癌模型中,瘤内注射灭活的MVA(iMVA)是有效的,并产生了适应性抗肿瘤免疫。与野生型小鼠相比,iMVA诱导的抗肿瘤治疗在STING或Batf3缺陷小鼠中效果较差,这表明胞质DNA感应和Batf3依赖的CD103/CD8α DC对iMVA免疫治疗都至关重要。在双侧肿瘤植入模型以及单侧大型既定肿瘤模型中,瘤内递送iMVA与全身递送免疫检查点阻断剂的联合产生了协同抗肿瘤作用。我们的结果表明,灭活的痘苗病毒可作为人类癌症的免疫治疗剂。

相似文献

1
Intratumoral delivery of inactivated modified vaccinia virus Ankara (iMVA) induces systemic antitumor immunity via STING and Batf3-dependent dendritic cells.瘤内递送灭活的安卡拉改良痘苗病毒(iMVA)通过STING和Batf3依赖性树突状细胞诱导全身抗肿瘤免疫。
Sci Immunol. 2017 May 19;2(11). doi: 10.1126/sciimmunol.aal1713.
2
Elucidating mechanisms of antitumor immunity mediated by live oncolytic vaccinia and heat-inactivated vaccinia.阐明活肿瘤溶瘤痘苗和热失活痘苗介导的抗肿瘤免疫的机制。
J Immunother Cancer. 2021 Sep;9(9). doi: 10.1136/jitc-2021-002569.
3
Heat-inactivated modified vaccinia virus Ankara boosts Th1 cellular and humoral immunity as a vaccine adjuvant.热灭活的改良安卡拉痘苗病毒作为疫苗佐剂可增强Th1细胞免疫和体液免疫。
NPJ Vaccines. 2022 Oct 19;7(1):120. doi: 10.1038/s41541-022-00542-5.
4
OX40L-expressing recombinant modified vaccinia virus Ankara induces potent antitumor immunity via reprogramming Tregs.OX40L 表达的重组改良安卡拉痘苗病毒通过重编程 Tregs 诱导有效的抗肿瘤免疫。
J Exp Med. 2023 Aug 7;220(8). doi: 10.1084/jem.20221166. Epub 2023 May 5.
5
Vector Aided Microenvironment programming (VAMP): reprogramming the TME with MVA virus expressing IL-12 for effective antitumor activity.向量辅助微环境编程(VAMP):用表达 IL-12 的 MVA 病毒重编程 TME 以实现有效的抗肿瘤活性。
J Immunother Cancer. 2023 Apr;11(4). doi: 10.1136/jitc-2023-006718.
6
The highly attenuated vaccinia virus strain modified virus Ankara induces apoptosis in melanoma cells and allows bystander dendritic cells to generate a potent anti-tumoral immunity.高度减毒的痘苗病毒株——安卡拉改良病毒,可诱导黑色素瘤细胞凋亡,并使旁观者树突状细胞产生强大的抗肿瘤免疫力。
Clin Exp Immunol. 2006 Nov;146(2):344-53. doi: 10.1111/j.1365-2249.2006.03177.x.
7
Epitope spreading driven by the joint action of CART cells and pharmacological STING stimulation counteracts tumor escape via antigen-loss variants.由 CART 细胞和药理学 STING 刺激的共同作用驱动的表位扩展通过抗原丢失变体对抗肿瘤逃逸。
J Immunother Cancer. 2021 Nov;9(11). doi: 10.1136/jitc-2021-003351.
8
Modified vaccinia virus Ankara for delivery of human tyrosinase as melanoma-associated antigen: induction of tyrosinase- and melanoma-specific human leukocyte antigen A*0201-restricted cytotoxic T cells in vitro and in vivo.用于递送人类酪氨酸酶作为黑色素瘤相关抗原的安卡拉改良痘苗病毒:在体外和体内诱导酪氨酸酶及黑色素瘤特异性的人类白细胞抗原A*0201限制性细胞毒性T细胞
Cancer Res. 1999 Oct 1;59(19):4955-63.
9
The lipid platform increases the activity of STING agonists to synergize checkpoint blockade therapy against melanoma.脂质平台可增强STING激动剂的活性,从而协同检查点阻断疗法治疗黑色素瘤。
Biomater Sci. 2021 Feb 7;9(3):765-773. doi: 10.1039/d0bm00870b. Epub 2020 Nov 17.
10
Integrity of the Antiviral STING-mediated DNA Sensing in Tumor Cells Is Required to Sustain the Immunotherapeutic Efficacy of Oncolytic Virus.肿瘤细胞中抗病毒的STING介导的DNA传感完整性是维持溶瘤病毒免疫治疗效果所必需的。
Cancers (Basel). 2020 Nov 17;12(11):3407. doi: 10.3390/cancers12113407.

引用本文的文献

1
New characteristics of cancer immunotherapy: trends in viral tumor immunotherapy with influenza virus-based approaches.癌症免疫疗法的新特征:基于流感病毒方法的病毒肿瘤免疫疗法趋势
J Zhejiang Univ Sci B. 2025 May 23;26(6):546-556. doi: 10.1631/jzus.B2400381.
2
HVJ-E links Apolipoprotein d to antitumor effects.仙台病毒包膜糖蛋白E将载脂蛋白d与抗肿瘤作用联系起来。
J Immunother Cancer. 2025 Jun 19;13(6):e011442. doi: 10.1136/jitc-2024-011442.
3
Oncolytic viruses as cancer therapeutics: From mechanistic insights to clinical translation.溶瘤病毒作为癌症治疗手段:从机制洞察到临床转化
Mol Ther. 2025 May 7;33(5):2217-2228. doi: 10.1016/j.ymthe.2025.03.035. Epub 2025 Mar 25.
4
Cross-priming in cancer immunology and immunotherapy.癌症免疫学与免疫治疗中的交叉呈递
Nat Rev Cancer. 2025 Apr;25(4):249-273. doi: 10.1038/s41568-024-00785-5. Epub 2025 Jan 29.
5
Virus replication is not required for oncolytic bovine herpesvirus-1 immunotherapy.溶瘤性牛疱疹病毒-1免疫疗法不需要病毒复制。
Mol Ther Oncol. 2024 Nov 18;32(4):200906. doi: 10.1016/j.omton.2024.200906. eCollection 2024 Dec 19.
6
Potential therapeutic strategies for colitis and colon cancer: bidirectional targeting STING pathway.结肠炎和结肠癌的潜在治疗策略:双向靶向STING通路
EBioMedicine. 2025 Jan;111:105491. doi: 10.1016/j.ebiom.2024.105491. Epub 2024 Dec 6.
7
cGAS/STING in skin melanoma: from molecular mechanisms to therapeutics.cGAS/STING 在皮肤黑色素瘤中的作用:从分子机制到治疗策略。
Cell Commun Signal. 2024 Nov 18;22(1):553. doi: 10.1186/s12964-024-01860-y.
8
Oncolytic immunotherapy with nivolumab in muscle-invasive bladder cancer: a phase 1b trial.纳武单抗用于肌肉浸润性膀胱癌的溶瘤免疫疗法:一项1b期试验。
Nat Med. 2025 Jan;31(1):176-188. doi: 10.1038/s41591-024-03324-9. Epub 2024 Nov 9.
9
High levels of tumor cell-intrinsic STING signaling are associated with increased infiltration of CD8 T cells in dMMR/MSI-H gastric cancer.高水平的肿瘤细胞固有 STING 信号与 dMMR/MSI-H 胃癌中 CD8 T 细胞浸润增加有关。
Sci Rep. 2024 Sep 6;14(1):20859. doi: 10.1038/s41598-024-71974-3.
10
A new MVA ancestor-derived oncolytic vaccinia virus induces immunogenic tumor cell death and robust antitumor immune responses.一种新型源自 MVA 的溶瘤痘苗病毒可诱导免疫原性肿瘤细胞死亡和强烈的抗肿瘤免疫反应。
Mol Ther. 2024 Jul 3;32(7):2406-2422. doi: 10.1016/j.ymthe.2024.05.014. Epub 2024 May 11.

本文引用的文献

1
Targeting T Cell Co-receptors for Cancer Therapy.靶向 T 细胞共受体进行癌症治疗。
Immunity. 2016 May 17;44(5):1069-78. doi: 10.1016/j.immuni.2016.04.023.
2
Expansion and Activation of CD103(+) Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition.肿瘤部位CD103(+)树突状细胞祖细胞的扩增与激活增强了肿瘤对治疗性PD-L1和BRAF抑制的反应。
Immunity. 2016 Apr 19;44(4):924-38. doi: 10.1016/j.immuni.2016.03.012.
3
PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations.用于癌症治疗的PD-L1(B7-H1)和PD-1通路阻断:作用机制、反应生物标志物及联合应用
Sci Transl Med. 2016 Mar 2;8(328):328rv4. doi: 10.1126/scitranslmed.aad7118.
4
Cancer Immunotherapy with Immunomodulatory Anti-CD137 and Anti-PD-1 Monoclonal Antibodies Requires BATF3-Dependent Dendritic Cells.使用免疫调节性抗CD137和抗PD-1单克隆抗体进行癌症免疫治疗需要BATF3依赖性树突状细胞。
Cancer Discov. 2016 Jan;6(1):71-9. doi: 10.1158/2159-8290.CD-15-0510. Epub 2015 Oct 22.
5
Oncolytic viruses: a new class of immunotherapy drugs.溶瘤病毒:一类新型免疫治疗药物。
Nat Rev Drug Discov. 2015 Sep;14(9):642-62. doi: 10.1038/nrd4663.
6
Genetic vaccines to potentiate the effective CD103+ dendritic cell-mediated cross-priming of antitumor immunity.增强有效的CD103+树突状细胞介导的抗肿瘤免疫交叉启动的基因疫苗。
J Immunol. 2015 Jun 15;194(12):5937-47. doi: 10.4049/jimmunol.1500089. Epub 2015 May 13.
7
Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity.黑色素瘤内在的β-连环蛋白信号抑制抗肿瘤免疫。
Nature. 2015 Jul 9;523(7559):231-5. doi: 10.1038/nature14404. Epub 2015 May 11.
8
Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity.肿瘤微环境中STING的直接激活导致强效且全身性的肿瘤消退和免疫。
Cell Rep. 2015 May 19;11(7):1018-30. doi: 10.1016/j.celrep.2015.04.031. Epub 2015 May 7.
9
Immune checkpoint blockade: a common denominator approach to cancer therapy.免疫检查点阻断:癌症治疗的一种通用方法。
Cancer Cell. 2015 Apr 13;27(4):450-61. doi: 10.1016/j.ccell.2015.03.001. Epub 2015 Apr 6.
10
The future of immune checkpoint therapy.免疫检查点疗法的未来。
Science. 2015 Apr 3;348(6230):56-61. doi: 10.1126/science.aaa8172.